ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

St. Jude Offers Three Fellowships

March 2, 1984

“Official Chronology” Of Gall/Montagnier Finding Agreed On; Royalties to Fund AIDS research

April 10, 1987

Final Count On Funded CCOPs Probably Delayed for Months; Many To Continue Without NCI Money

April 24, 1987

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

AACR Using Its Clout To Urge Higher NCI Budget

May 24, 1991

Planned Parenthood May Be Doing Harm By Selling Breast Cancer Screening to Women Under 40

February 10, 2012